167 related articles for article (PubMed ID: 37974206)
1. The impact of fibrotic diseases on global mortality from 1990 to 2019.
Mutsaers HAM; Merrild C; Nørregaard R; Plana-Ripoll O
J Transl Med; 2023 Nov; 21(1):818. PubMed ID: 37974206
[No Abstract] [Full Text] [Related]
2. Function and regulation of GPX4 in the development and progression of fibrotic disease.
Li Z; Zhu Z; Liu Y; Liu Y; Zhao H
J Cell Physiol; 2022 Jul; 237(7):2808-2824. PubMed ID: 35605092
[TBL] [Abstract][Full Text] [Related]
3. An American Thoracic Society Official Research Statement: Future Directions in Lung Fibrosis Research.
White ES; Borok Z; Brown KK; Eickelberg O; Guenther A; Jenkins RG; Kolb M; Martinez FJ; Roman J; Sime P;
Am J Respir Crit Care Med; 2016 Apr; 193(7):792-800. PubMed ID: 27035782
[TBL] [Abstract][Full Text] [Related]
4. Fibrosis score predicts mortality in patients with fibrotic hypersensitivity pneumonitis.
Oh JH; Kang J; Song JW
Front Med (Lausanne); 2023; 10():1131070. PubMed ID: 37025957
[TBL] [Abstract][Full Text] [Related]
5. Hydrogen Sulfide: A Therapeutic Candidate for Fibrotic Disease?
Song K; Li Q; Yin XY; Lu Y; Liu CF; Hu LF
Oxid Med Cell Longev; 2015; 2015():458720. PubMed ID: 26078807
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia enhances anti-fibrotic properties of extracellular vesicles derived from hiPSCs via the miR302b-3p/TGFβ/SMAD2 axis.
Paw M; Kusiak AA; Nit K; Litewka JJ; Piejko M; Wnuk D; Sarna M; Fic K; Stopa KB; Hammad R; Barczyk-Woznicka O; Cathomen T; Zuba-Surma E; Madeja Z; Ferdek PE; Bobis-Wozowicz S
BMC Med; 2023 Oct; 21(1):412. PubMed ID: 37904135
[TBL] [Abstract][Full Text] [Related]
7. Human Fibrotic Diseases: Current Challenges in Fibrosis Research.
Rosenbloom J; Macarak E; Piera-Velazquez S; Jimenez SA
Methods Mol Biol; 2017; 1627():1-23. PubMed ID: 28836191
[TBL] [Abstract][Full Text] [Related]
8. Antisynthetase syndrome-related interstitial lung disease (ASyS-ILD): longitudinal imaging findings.
Wu W; Collins BF; Gardner GC; Hippe DS; Ho LA; Raghu G; Pipavath SNJ
Eur Radiol; 2023 Jul; 33(7):4746-4757. PubMed ID: 36786906
[TBL] [Abstract][Full Text] [Related]
9. Increasing global mortality from idiopathic pulmonary fibrosis in the twenty-first century.
Hutchinson JP; McKeever TM; Fogarty AW; Navaratnam V; Hubbard RB
Ann Am Thorac Soc; 2014 Oct; 11(8):1176-85. PubMed ID: 25165873
[TBL] [Abstract][Full Text] [Related]
10. T Cells in Fibrosis and Fibrotic Diseases.
Zhang M; Zhang S
Front Immunol; 2020; 11():1142. PubMed ID: 32676074
[TBL] [Abstract][Full Text] [Related]
11. The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms.
Wang Y; Jiao L; Qiang C; Chen C; Shen Z; Ding F; Lv L; Zhu T; Lu Y; Cui X
Biomed Pharmacother; 2024 Feb; 171():116116. PubMed ID: 38181715
[TBL] [Abstract][Full Text] [Related]
12. From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis.
Bonham CA; Strek ME; Patterson KC
Curr Opin Pulm Med; 2016 Sep; 22(5):484-91. PubMed ID: 27379967
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol exerts dose-dependent anti-fibrotic or pro-fibrotic effects in kidneys: A potential risk to individuals with impaired kidney function.
Liu S; Zhao M; Zhou Y; Wang C; Yuan Y; Li L; Bresette W; Chen Y; Cheng J; Lu Y; Liu J
Phytomedicine; 2019 Apr; 57():223-235. PubMed ID: 30785018
[TBL] [Abstract][Full Text] [Related]
14. The emerging roles of β-arrestins in fibrotic diseases.
Gu YJ; Sun WY; Zhang S; Wu JJ; Wei W
Acta Pharmacol Sin; 2015 Nov; 36(11):1277-87. PubMed ID: 26388156
[TBL] [Abstract][Full Text] [Related]
15. Targeting fatty acid metabolism for fibrotic disorders.
Hwang S; Chung KW
Arch Pharm Res; 2021 Oct; 44(9-10):839-856. PubMed ID: 34664210
[TBL] [Abstract][Full Text] [Related]
16. The controversial role of retinoic acid in fibrotic diseases: analysis of involved signaling pathways.
Zhou TB; Drummen GP; Qin YH
Int J Mol Sci; 2012 Dec; 14(1):226-43. PubMed ID: 23344030
[TBL] [Abstract][Full Text] [Related]
17. Shared and distinct mechanisms of fibrosis.
Distler JHW; Györfi AH; Ramanujam M; Whitfield ML; Königshoff M; Lafyatis R
Nat Rev Rheumatol; 2019 Dec; 15(12):705-730. PubMed ID: 31712723
[TBL] [Abstract][Full Text] [Related]
18. The emerging roles of ferroptosis in organ fibrosis and its potential therapeutic effect.
Huang X; Song Y; Wei L; Guo J; Xu W; Li M
Int Immunopharmacol; 2023 Mar; 116():109812. PubMed ID: 36746022
[TBL] [Abstract][Full Text] [Related]
19. Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars.
Vanderstichele S; Vranckx JJ
World J Stem Cells; 2022 Feb; 14(2):200-213. PubMed ID: 35432731
[TBL] [Abstract][Full Text] [Related]
20. Role of Extracellular Vesicles in the Propagation of Lung Fibrosis in Systemic Sclerosis.
Mouawad JE; Sanderson M; Sharma S; Helke KL; Pilewski JM; Nadig SN; Feghali-Bostwick C
Arthritis Rheumatol; 2023 Dec; 75(12):2228-2239. PubMed ID: 37390364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
